Trial Profile
Feasibility Pilot Study Assessing the Impact on the Quality of Hospital Care After the Introduction of Rotavirus Vaccination in Belgium
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 31 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Jun 2014 Planned End Date changed from 1 Jan 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov record.
- 08 Jun 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.